RWHAP Part C and D Stakeholders Webinar - October 2022
Resource updated 01/10/2024
Resource updated 01/10/2024
Resource from the RWHAP Best Practices Compilation updated on 02/12/2024
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Discussion of the SPNS Black MSM Initiatives challenges and solutions to addressing program and client engagement disruptions.
Resource (Conference Presentation) updated 09/14/2023
Outreach strategies to better serve rural MSM populations impacted by cultural, geographic, and resource-related barriers to HIV testing.
Resource (Conference Presentation) updated 09/14/2023
Overview of Medicare eligibility and enrollment for people with HIV and support and training options available to agencies and people with HIV, including persons aging with HIV.
Resource (Conference Presentation) updated 09/14/2023
Update on federal and state healthcare and health coverage policies impacting RWHAP agencies.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 04/17/2024
Resource (Conference Presentation) updated 09/14/2023
Resource updated 03/04/2024
HRSA's HIV/AIDS Bureau's Division of Community HIV/AIDS Programs (DCHAP) held a session for recipients.
Resource (Conference Presentation) updated 09/14/2023
By cross matching registries of HIV and other sexually transmitted infections, this study found 27.1% of male syphilis cases were coinfected with HIV and 31.8% of those coinfected were not virally suppressed. This suggests ongoing sexual risk behaviors and the potential for HIV transmission among male syphilis cases.
Resource (Conference Presentation) updated 09/14/2023
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
People aging with HIV are at increased risk and experience an array of comorbidities including diabetes, cardiovascular disease, and neurocognitive impairment. This poster will demonstrate the implementation of Medicare Wellness Visits, outcome data and lessons learned.
Resource (Conference Presentation) updated 09/14/2023
Overview of barriers and facilitators to Pap test utilization for women with HIV who receive RWHAP Part D services. Using the Socio-Ecological Model, the individual, interpersonal, community, and healthcare system level barriers and facilitators are explored.
Resource (Conference Presentation) updated 09/14/2023
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
Review of the SPNS demonstration site efforts to understand and integrate mental and behavioral health services and address the unmet needs of Black MSM.
Resource (Conference Presentation) updated 09/14/2023
Final Findings from the SPNS Black MSM Initiative Multi-site Evaluation.
Resource (Conference Presentation) updated 09/14/2023